T1 Energy Inc. (TE): what the price assumes

In the published model solve dated 2026-Q2, anchored at $5.47, T1 Energy Inc. (TE) is priced for today's economics sustained for ~22.1 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/TE

Headline

FieldValue
TickerTE
CompanyT1 Energy Inc.
Sector / IndustryTechnology
Current price$5.48/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid3.5x
Steady-state operating margin assumed2.9%
Must persist for22.1y

Solve inputs: computed at a 11.4% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.9 years.

Reconcile: at the x-ray's 9.3% required return this reads ~16.3 years; the models below use their own rates.

How unusual the bet is: elevated (limited comparison data)

ReferenceValue
sustained it ~10 years at this level15%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset6.82x2expensive
Earnings0
Relative0.35x2justifies
Growth0.50x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.

Per-Model Detail (n=7)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$10.880.50xyesReference only (OCF-based, capex excluded): OCF $0.1B
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$15.750.35xyesP/S fallback (negative EPS): Sector P/S 5.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$0.856.44xyesBook value floor: BV/sh $0.85, ROE negative
Two-Stage Excess ReturnAsset$0.767.20xyesBook value with convergence: BV/sh $0.85, ROE converges to ke
Discounted Future Market CapGrowth$7.940.69xyesRev $0.9B, growth 30% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.7x / 2.1x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$26.670.21xyesMargin ramp: -42% → 25% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$15.750.35xyesRevenue $0.88B × sector P/S 5.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
PV Solar Modules (whole-company)operatingenterprise0.8B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$332.0m
Share count CAGR (dilution)26.9%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The reasons to walk away from T1 Energy are sitting in plain view. The company loses money at the operating line, with a trailing operating margin around negative 27 percent. One buyer took 78 percent of last year's sales. The share count has compounded upward at roughly 27 percent a year, which means every existing holder's claim on the eventual prize keeps shrinking. Those are the fears. The question is whether the recent data supports them or is starting to undermine them, and the trajectory says the latter.

Start with the top line. First-quarter sales came in at $177.7 million against $53.5 million a year earlier, and the quarter produced $3.9 million of net income from continuing operations alongside the company's first meaningful positive adjusted EBITDA, at $9.1 million. A module plant that was barely shipping a year ago is now running at a revenue pace near $700 million annualized, and the losses that dominate the trailing twelve months are increasingly a picture of the past four quarters rather than the next four. The demand side is doing most of the work: the 10-K points to "robust customer demand for high domestic content solar equipment" and a U.S. market with "more than 45 GWdc forecast through 2030" across utility-scale and commercial segments. T1 is one of a small set of manufacturers positioned to sell American-made modules into that pipeline.

The structural piece of the bull case is vertical integration. Today T1 assembles modules in Dallas from imported cells; the G2 Austin facility is designed to make the cells themselves, which captures more of the federal 45X production credit per watt and hardens the domestic-content claim that customers are paying for. Concrete work began in April, structural steel followed in May, and management still targets first production in the fourth quarter of 2026, with the phase-one financing requirement of roughly $225 million already addressed by a convertible notes offering at a 4.00 percent coupon that raised about $175 million net. The June acquisition of Kore Power for $32 million adds battery capability on top. None of this removes the concentration or dilution problems. It does mean the company that reports 2027 results will look structurally different from the one that produced the trailing numbers, and the market is being asked to price the former.

Bear Case

Today's price is not paying for the module plant in Dallas. It is paying for a specific sequence of future events: the Austin cell facility starts producing on schedule in late 2026, the ramp reaches the $375 to $450 million of adjusted EBITDA management has sketched for 2027, federal 45X credits keep flowing at current rates, and module prices hold while all of that happens. Each link is plausible. The bet requires all of them, and the most fragile link is the one the company controls least. The 10-K flags that "Any changes to the statutes or regulatory guidance regarding Section 45X of the IRC" could move the economics, and a manufacturing story whose margin structure leans on a tax credit is exposed to a pen stroke in Washington in a way no operational excellence can hedge.

The competitive backdrop compounds the fragility. T1's own filing describes competitors, many in China, that may sell "below their manufacturing costs, in order to generate sales, and may do so for a sustained period", with "direct or indirect access to sovereign capital or other forms of state support", and warns that "excess capacity will continue to put pressure on pricing". Tariff walls and domestic-content rules are the counterweight, but those are policy artifacts too, which routes the bear case back to the same dependency: the moat here is substantially legislative. Meanwhile the revenue base rests on a single relationship. The FY2025 10-K discloses one customer at 78 percent of total net sales, so a renegotiation, a delayed project pipeline, or a lost contract does not dent the story, it removes most of it.

The balance sheet leaves little room for the schedule to slip. Net debt stands at $332 million, liquid assets at roughly $46 million, and operating profit is still negative, so conventional coverage math does not yet apply to this company. Funding has come from the equity and convertible markets, and the share count has grown about 27 percent a year for three years, a pace that transfers value from existing holders every time the company needs capital. At about 4.3 times revenue, the price already embeds the business growing at the fastest pace it can fund internally for roughly 25 years; of comparable fast-growers, only about 15 percent have sustained that kind of pace for even a decade. If the Austin ramp lands late or lean, the next capital raise happens from a weaker position, and the dilution machine that funded the buildout keeps running against the holders who financed it.

Valuation

At $6.86, the market is paying about 4.3 times revenue for a business that currently runs a negative 27 percent operating margin. Worked backward, that price implies T1 eventually earns an operating margin of roughly 2.9 percent while growing revenue at its self-funding ceiling, the fastest pace it can finance without new capital, for something like 25 years. Keep those figures approximate; they describe the shape of the bet rather than a measurement. The striking part is not the margin, which is thin even by manufacturing standards, but the duration: of comparable fast-growing companies, only about 15 percent sustained that pace for even ten years.

The methods disagree along a clean fault line. The asset-value lens is brutal: book value sits near $0.83 per share, so the price stands at close to nine times what balance-sheet-based approaches support. No earnings-power method applies at all, because there are no positive earnings to capitalize. What reaches the price is the forward-looking side: a sales-multiple comparison against the sector lands well above today's level, and the growth projections get there only by assuming revenue compounds around 30 percent with losses swinging to strongly positive margins over roughly seven years, with the terminal multiple held flat at today's level. The pattern is the signal. Everything that anchors on what the company has already demonstrated finds the stock expensive; everything that anchors on what the ramp could produce finds it cheap. The price sits entirely on the ramp.

Two filing-sourced facts bound the range of outcomes. On the revenue input, one customer accounted for 78 percent of FY2025 net sales, so the top line the multiples rest on is closer to a single contract than a diversified book. On the margin input, the 10-K itself warns of "substantial downward pressure on the prices of solar cells and modules" from industry overcapacity, which is direct pressure on the thin terminal margin the price requires. The balance sheet frames the downside: $332 million of net debt against about $46 million of liquid assets, debt language in the filing acknowledging terms that "make it more difficult to satisfy our financial obligations, including payments on our indebtedness", and a share count rising about 27 percent a year as the buildout is financed. The Austin plant is the whole valuation question; the balance sheet is the clock it runs against.

Catalysts

The first quarter, reported May 12, 2026, marked the inflection the story needs: sales of $177.7 million versus $53.5 million a year earlier, net income from continuing operations of $3.9 million, and record adjusted EBITDA of $9.1 million, though the bottom line still showed a $21.4 million net loss attributable to common stockholders, about $0.08 per share, driven by discontinued operations. Management framed 2026 as a bridge year, with the real earnings power arriving in 2027 at a targeted $375 to $450 million of adjusted EBITDA once cell production scales.

The G2 Austin facility is the calendar that matters. Concrete works commenced in April 2026, first structural steel went up in May, and the company continues to target initial cell production in the fourth quarter of 2026. Financing for the roughly $225 million phase-one requirement was substantially addressed by a 4.00 percent convertible notes offering completed in the first quarter. On June 30, 2026 the company added a $32 million acquisition of Kore Power, funded with a mix of equity, cash, and assumed debt, extending the platform into battery storage.

The watch items from here are sequential: the second-quarter print for evidence the module business held its first-quarter pace, construction milestones at Austin through the summer and fall, and any Washington movement on Section 45X guidance, which sets the credit economics the 2027 targets lean on. Analysts have recently trimmed price targets on softer revenue growth and margin assumptions, so the burden of proof sits on execution rather than sentiment.

Peer Cohorts (Per Segment, With Filing Citations)

PV Solar Modules (whole-company) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release and call, May 12, 2026 · Q1 2026 earnings release, May 12, 2026 · company announcement, June 30, 2026 · Q1 2026 earnings call, May 12, 2026 · Simply Wall St, June 2026

View the full interactive TE report on boothcheck